FTC puts drugmakers and PBMs on notice that it will crack down on illegal rebate schemes

In a notable move, the Federal Trade Commission put drugmakers and pharmacy benefit managers on notice that the agency will “ramp up enforcement” of any “illegal bribes and rebate schemes” that make it harder for patients to access lower-cost medicines.

Read the full story >